Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01118884|
Recruitment Status : Unknown
Verified April 2010 by Shahid Beheshti University.
Recruitment status was: Active, not recruiting
First Posted : May 7, 2010
Last Update Posted : May 7, 2010
|Condition or disease||Intervention/treatment||Phase|
|Conscious Sedation||Drug: Promethazine||Phase 3|
The effectiveness of oral midazolam in pediatric dentistry is controversial. Usefulness of midazolam alone is limited to short-duration procedures, and we are needed to identify safe oral conscious regiments which permit longer duration procedures in dental treatments especially in Pediatric dentistry.
Promethazine is a long-acting (4-12 hr) anti-histaminic, H1 antagonist drug which acts as a central nervous system depressant and showing itself to be a weak anxiolytic drug.
The hypothesis to be tested is whether promethazine would improve the patients behavior during dental procedures without affecting vital signs, thus enabling longer periods of moderate or conscious sedation.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||Sedative Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide/Oxygen on Behavior Management of Uncooperative Children Receiving Dental Treatment|
|Study Start Date :||June 2009|
|Estimated Primary Completion Date :||April 2010|
|Estimated Study Completion Date :||May 2010|
20 healthy uncooperative children aged 36-96 months were examined in a cross-over study design , each patient served as his/her own control. Each patient was assigned randomly to received 1 of 2 drug regimens for initial sedation session and the other regimen administered at second session which was one week later.
Syrup ,1 mg/kg, oral , 30 minutes before dental procedure , its duration is 4-6 hours
- Behavior change [ Time Frame: during dental treatment which is 30 minutes after drug ingestion ]Behavior evaluation was based on a scale proposed by Houpt et al. which establishes the following scores : sleep, movement, crying , overall behavior.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01118884
|Iran, Islamic Republic of|
|Dental school of Shahid Beheshti University of Medical Sciences|
|Tehran, Iran, Islamic Republic of, 19839|
|Principal Investigator:||Sedighe Mozaffar||Postgraduate student of Shahid Beheshti Medicine University|